# Bioventus Inc.: Form 8-K, filed May 12, 2021

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2021-05-12
- Accepted by EDGAR: May 12, 2021, 16:23 ET
- Period: 2021-05-12
- Accession: 0001628280-21-010016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828021010016/bvs-20210512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828021010016/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828021010016/bvs-20210512.htm

Filed May 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001628280-21-010016. Last ingested by Listed: Nov 14, 2026, 17:43 ET. No prices; not investment advice.
